VYLOY Trademark

Trademark Overview

On Thursday, October 13, 2022, a trademark application was filed for VYLOY with the United States Patent and Trademark Office. The USPTO has given the VYLOY trademark a serial number of 79356468. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Astellas Pharma Inc.. The VYLOY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer and for gastro-intestinal disorders and diseases
vyloy

General Information

Serial Number79356468
Word MarkVYLOY
Filing DateThursday, October 13, 2022
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7349510
Registration DateTuesday, April 9, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements

Description of MarkThe mark consists of the wording VYLOY in blue and grey, and a purple sector of a circle within the V.
Goods and ServicesPharmaceutical preparations for the treatment of cancer and for gastro-intestinal disorders and diseases
Indication of Colors claimedThe color(s) blue, purple and grey is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Sunday, June 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 1, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 6, 2022APPLICATION FILING RECEIPT MAILED
Saturday, June 24, 2023LIMITATION OF GOODS RECEIVED FROM IB
Friday, July 28, 2023ASSIGNED TO EXAMINER
Thursday, August 10, 2023NON-FINAL ACTION WRITTEN
Friday, August 11, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 1, 2023REFUSAL PROCESSED BY MPU
Friday, September 1, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 25, 2023REFUSAL PROCESSED BY IB
Monday, October 9, 2023LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, December 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 3, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, January 22, 2024NOTIFICATION PROCESSED BY IB
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

vyloy intestinal disorders diseases gastro cancer preparations treatment pharmaceutical